It is an inverse leveraged exchange-traded fund designed to move in the opposite direction of the daily performance of the Health Care Select Sector Index. It aims to respond to daily declines in the health care sector, but the longer the holding period, the more cumulative performance can differ from the daily target.

It is suited to experienced investors who want to use inverse exposure when the health care sector is weak in the short term, and who can review risk every day.

This is a passively managed (index-tracking) ETF operated by ProShares.

The product is managed with a combination of derivatives and cash-equivalent assets, aiming for leveraged exposure opposite to the daily movement of the underlying index. Because the target is set on a daily basis, the more the market keeps fluctuating, the more the compounding effect can create a large difference in cumulative performance.

• Daily inverse exposure that responds to declines in the health care sector
• Leveraged management structure aligned with the daily target

Assets under management (AUM) stand at $3.2M, and the expense ratio is 0.95% per year.

Liquidity and the fee structure should be checked at the time of trading, and given the nature of a daily-target product, the performance gap that arises over the holding period also needs to be reviewed.

The RXD ETF is structured to react sensitively, in the opposite direction, to the direction and daily volatility of the health care sector. When the sector is trending higher, it can come under downward pressure, and when volatility rises, the gap between the daily target and cumulative performance can also widen.

Sector-specific catalysts such as health care company earnings, regulatory changes, drug prices, and clinical trial results can affect the volatility of the underlying index and the fund flows of related products. Even when market uncertainty rises, whether inverse exposure is appropriate depends on the investment horizon and the risk management plan.

Its structure for responding to sector declines is a strength, but the compounding effect and concentrated exposure can raise the risk of long-term holding.

The SQQQ ETF is a Nasdaq-focused inverse leveraged product with relatively large assets among the comparison group, while the SOXS ETF is a product that responds to declines in the semiconductor industry and has a relatively high cost burden. The SH ETF offers simple inverse exposure to the broad US stock market, and the PSQ ETF offers simple inverse exposure centered on the Nasdaq. The SPXU ETF can be compared as leveraged inverse exposure to the broad market. Unlike these, the RXD ETF is a daily inverse product focused on the health care sector, so the tracked target, degree of leverage, and fee structure should be reviewed together.

The structure of a daily-target product can create a gap between a short-term view and long-term holding results. When considering the RXD ETF, investors should look at their view on the health care sector, their tolerance for volatility, and the nature of distributions and cost burden together.

Even when a directional call is right, leveraged inverse products can deliver period performance that differs from expectations because of volatility and the compounding effect. Sector factors such as health care policy, regulation, clinical trial results, and drug prices can also amplify moves in the underlying index, so the range of tolerable losses should be set in advance.

The RXD ETF is a tool that reflects a short-term inverse view on a weak health care phase. However, because it is a daily-target product, it is not a substitute for long-term holding, and it should be considered only in a limited way as a risk management tool after the purpose and holding period have been clearly defined.